In certain cases, activation of the RANKL/RANK signaling pathway induces immunosuppressive molecules (e.g., TGF-β from Treg cells), regulating the immune response balance, allowing lung cancer cells to evade immune surveillance and promote bone metastasis (67). Here, TGFB1 is linked to lung carcinoma.